Shengming Deng

2.8k total citations · 1 hit paper
82 papers, 1.9k citations indexed

About

Shengming Deng is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shengming Deng has authored 82 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 32 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shengming Deng's work include Medical Imaging Techniques and Applications (18 papers), Radiomics and Machine Learning in Medical Imaging (16 papers) and Pancreatic and Hepatic Oncology Research (15 papers). Shengming Deng is often cited by papers focused on Medical Imaging Techniques and Applications (18 papers), Radiomics and Machine Learning in Medical Imaging (16 papers) and Pancreatic and Hepatic Oncology Research (15 papers). Shengming Deng collaborates with scholars based in China, United States and Fiji. Shengming Deng's co-authors include Guopei Luo, Xianjun Yu, Yunzhen Qian, Chen Liu, Yitao Gong, Zhiyao Fan, Kaizhou Jin, Qiuyi Huang, Cheng He and Quanxing Ni and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Shengming Deng

81 papers receiving 1.9k citations

Hit Papers

Roles of CA19-9 in pancreatic cancer: Biomarker, predicto... 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter
    2020 251 citations Guopei Luo, Kaizhou Jin et al. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengming Deng China 21 860 497 487 407 343 82 1.9k
Anita I. Kapanen Canada 17 1.2k 1.4× 673 1.4× 775 1.6× 441 1.1× 124 0.4× 42 2.2k
Rainer Kehlbach Germany 25 815 0.9× 410 0.8× 1.1k 2.4× 507 1.2× 367 1.1× 57 2.4k
Jinming Yu China 19 1.2k 1.4× 249 0.5× 579 1.2× 671 1.6× 456 1.3× 66 2.3k
Jae Hong Seo South Korea 27 1.6k 1.9× 330 0.7× 859 1.8× 523 1.3× 818 2.4× 142 3.1k
Andrew R. Clamp United Kingdom 24 739 0.9× 200 0.4× 734 1.5× 276 0.7× 227 0.7× 116 2.0k
Yanling Ma United States 28 762 0.9× 385 0.8× 609 1.3× 766 1.9× 418 1.2× 100 2.7k
James Paget United Kingdom 10 791 0.9× 230 0.5× 587 1.2× 399 1.0× 397 1.2× 21 1.9k
Hannelore Denys Belgium 28 1.3k 1.5× 331 0.7× 1.1k 2.4× 358 0.9× 734 2.1× 148 3.1k
Quan‐Yong Luo China 28 707 0.8× 696 1.4× 433 0.9× 432 1.1× 229 0.7× 122 2.4k
Ming Kuang China 31 665 0.8× 323 0.6× 896 1.8× 604 1.5× 605 1.8× 90 3.6k

Countries citing papers authored by Shengming Deng

Since Specialization
Citations

This map shows the geographic impact of Shengming Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengming Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengming Deng more than expected).

Fields of papers citing papers by Shengming Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengming Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengming Deng. The network helps show where Shengming Deng may publish in the future.

Co-authorship network of co-authors of Shengming Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Shengming Deng. A scholar is included among the top collaborators of Shengming Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengming Deng. Shengming Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Shengming, et al.. (2025). Assessment of Fish Species Biodiversity in the Yong River Basin Based on Environmental DNA Metabarcoding. Diversity. 17(1). 35–35. 2 indexed citations
2.
3.
Ge, Shushan, Tongtong Jia, Shibiao Sang, et al.. (2024). A cutting-edge 68Ga-labeled bicyclic peptide PET molecular probe for noninvasive assessment of Nectin4 expression. Bioorganic Chemistry. 152. 107745–107745. 3 indexed citations
4.
Zhu, Yunkai, et al.. (2024). Diagnostic value of Tc-99m-MIBI SPECT/CT in parathyroid carcinoma with lung metastasis: a case report and literature review. Frontiers in Oncology. 14. 1501447–1501447. 1 indexed citations
5.
Yang, Yi, et al.. (2023). The Differential Diagnostic Value of Radiomics Signatures Between Single-Nodule Pulmonary Metastases and Second Primary Lung Cancer in Patients with Colorectal Cancer. Technology in Cancer Research & Treatment. 22. 2223917623–2223917623. 3 indexed citations
6.
Ge, Shushan, Bin Zhang, Jihui Li, et al.. (2023). A novel 68Ga-labeled cyclic peptide molecular probe based on the computer-aided design for noninvasive imaging of PD-L1 expression in tumors. Bioorganic Chemistry. 140. 106785–106785. 5 indexed citations
7.
Qian, Yunzhen, Yitao Gong, Guopei Luo, et al.. (2022). Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreas. World Journal of Surgical Oncology. 20(1). 310–310. 3 indexed citations
8.
Deng, Shengming, Zhiyao Fan, Yitao Gong, et al.. (2021). Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms. Cancer Management and Research. Volume 13. 107–115. 13 indexed citations
9.
Zhang, Naidong, Pei Zhou, Xiaomei Liu, et al.. (2021). DLL1 orchestrates CD8+T cells to induce long-term vascular normalization and tumor regression. Proceedings of the National Academy of Sciences. 118(22). 40 indexed citations
10.
Chen, Zhiqiang, et al.. (2021). Radiomic Features of 18F-FDG PET in Hodgkin Lymphoma Are Predictive of Outcomes. Contrast Media & Molecular Imaging. 2021. 1–8. 22 indexed citations
11.
Ge, Shushan, Jihui Li, Zhengguo Chen, et al.. (2021). Review: Radionuclide Molecular Imaging Targeting HER2 in Breast Cancer with a Focus on Molecular Probes into Clinical Trials and Small Peptides. Molecules. 26(21). 6482–6482. 18 indexed citations
12.
Zhang, Xiaoyi, Haifeng Qin, Jihui Li, et al.. (2020). Prognostic Values of Baseline 18F‐FDG PET/CT in Patients with Peripheral T‐Cell Lymphoma. BioMed Research International. 2020(1). 9746716–9746716. 13 indexed citations
13.
Qian, Yunzhen, Yitao Gong, Zhiyao Fan, et al.. (2020). Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma. Journal of Hematology & Oncology. 13(1). 130–130. 231 indexed citations
14.
Fan, Zhiyao, Kun Fan, Shengming Deng, et al.. (2020). HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLR. Acta Biochimica et Biophysica Sinica. 52(3). 241–250. 5 indexed citations
15.
Luo, Guopei, Kaizhou Jin, Shengming Deng, et al.. (2020). Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1875(2). 188409–188409. 251 indexed citations breakdown →
16.
Deng, Shengming, et al.. (2018). The Role of18F-FDG PET/CT in Multiple Myeloma Staging according to IMPeTUs: Comparison of the Durie–Salmon Plus and Other Staging Systems. Contrast Media & Molecular Imaging. 2018. 1–9. 20 indexed citations
17.
Zheng, Xichen, Xiaomei Liu, Shengming Deng, et al.. (2018). Increased vessel perfusion predicts the efficacy of immune checkpoint blockade. Journal of Clinical Investigation. 128(5). 2104–2115. 183 indexed citations
18.
19.
Deng, Shengming, Guoxi Zhang, Peng Fan, et al.. (2018). Lentinan inhibits tumor angiogenesis via interferon γ and in a T cell independent manner. Journal of Experimental & Clinical Cancer Research. 37(1). 260–260. 53 indexed citations
20.
Yang, Huilin, Tao Liu, Ximing Wang, Yong Xu, & Shengming Deng. (2011). Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy. European Radiology. 21(12). 2604–2617. 240 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anita I. Kapanen Breakdown of academic impact, for papers by Rainer Kehlbach Breakdown of academic impact, for papers by Jinming Yu Breakdown of academic impact, for papers by Jae Hong Seo Breakdown of academic impact, for papers by Andrew R. Clamp Breakdown of academic impact, for papers by Yanling Ma Breakdown of academic impact, for papers by James Paget Breakdown of academic impact, for papers by Hannelore Denys Breakdown of academic impact, for papers by Quan‐Yong Luo Breakdown of academic impact, for papers by Ming Kuang
Rankless by CCL
2026